Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of ...

Sage’s board of directors said Biogen’s offer “undervalues” the company, but will explore other strategic alternatives to ...

Business Insider's personal finance team compared Sage Mortgage to the best mortgage lenders and found it to be a standard lender Sage Mortgage has loan options that should meet most borrowers ...

Sage Therapeutics, Inc. (NASDAQ:SAGE) stock climbed 2.5% today, reflecting investor sentiment after the company announced the ...

Sage Potash Corp. ( ($TSE:SAGE) ) just unveiled an announcement. Sage Potash Corp. has successfully closed a C$2.5 million private placement, ...

ISS has recommended that investors vote against Sage's pay policy at next month's AGM, in what could be the year's first big flashpoint over boardroom pay, Sky News learns.

Biogen proposed acquiring Sage Therapeutics for $7.22 per share; Sage stock has dropped 90% in five years. Sage reorganized in October, cutting 165+ jobs and shifting focus to Zurzuvae for ...

(Alliance News) - Sage Group PLC on Thursday said revenue grew nearly 10% during the first quarter of its current financial year, and reiterates its growth forecast.

The company said Biogen's offer to buy all outstanding shares of Sage that it does not already own for $7.22 apiece, ...

On Friday, Sage Therapeutics Inc. (NASDAQ:SAGE) confirmed that Biogen Inc. (NASDAQ:BIIB) submitted an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics ...